Sanofi Consumer Healthcare India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
SANOFICONR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sanofi Consumer Healthcare India has informed the exchanges that its trading window will be closed from 1st April 2026 until 48 hours after the announcement of its unaudited standalone financial results for the quarter ended 31st March 2026. This is a standard compliance measure under SEBI's Insider Trading Regulations, 2015, aimed at preventing insider trading during a sensitive financial reporting period. Designated persons are restricted from trading in the company's shares during this window. The letter is signed by Nikunjkumar Savaliya, Company Secretary and Compliance Officer.
This is a routine regulatory filing with no direct impact on shareholders. It simply signals that the company's Q4 FY26 financial results are upcoming, which investors should watch for.